| Year |
Citation |
Score |
| 2024 |
Reuven AD, Mwaura BW, Bliska JB. ExoS Effector in Hyperactive Type III Secretion System Mutant Promotes Enhanced Plasma Membrane Rupture in Neutrophils. Biorxiv : the Preprint Server For Biology. PMID 38328038 DOI: 10.1101/2024.01.24.577040 |
0.348 |
|
| 2022 |
Oh C, Li L, Verma A, Reuven AD, Miao EA, Bliska JB, Aachoui Y. Neutrophil inflammasomes sense the subcellular delivery route of translocated bacterial effectors and toxins. Cell Reports. 41: 111688. PMID 36417874 DOI: 10.1016/j.celrep.2022.111688 |
0.317 |
|
| 2021 |
Bliska JB, Brodsky IE, Mecsas J. Role of the Yersinia pseudotuberculosis Virulence Plasmid in Pathogen-Phagocyte Interactions in Mesenteric Lymph Nodes. Ecosal Plus. 9: eESP00142021. PMID 34910573 DOI: 10.1128/ecosalplus.ESP-0014-2021 |
0.368 |
|
| 2020 |
Malik HS, Bliska JB. The pyrin inflammasome and the Yersinia effector interaction. Immunological Reviews. PMID 32721043 DOI: 10.1111/Imr.12907 |
0.408 |
|
| 2020 |
Park YH, Remmers EF, Lee W, Ombrello AK, Chung LK, Shilei Z, Stone DL, Ivanov MI, Loeven NA, Barron KS, Hoffmann P, Nehrebecky M, Akkaya-Ulum YZ, Sag E, Balci-Peynircioglu B, ... ... Bliska JB, et al. Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis. Nature Immunology. PMID 32601469 DOI: 10.1038/S41590-020-0705-6 |
0.317 |
|
| 2020 |
Loeven NA, Medici NP, Bliska JB. The pyrin inflammasome in host-microbe interactions. Current Opinion in Microbiology. 54: 77-86. PMID 32120337 DOI: 10.1016/J.Mib.2020.01.005 |
0.452 |
|
| 2019 |
McLaughlin PA, Bettke JA, Tam JW, Leeds J, Bliska JB, Butler BP, van der Velden AWM. Inflammatory monocytes provide a niche for Salmonella expansion in the lumen of the inflamed intestine. Plos Pathogens. 15: e1007847. PMID 31306468 DOI: 10.1371/Journal.Ppat.1007847 |
0.368 |
|
| 2019 |
Medici NP, Bliska JB. Methods for Detection of Pyrin Inflammasome Assembly in Macrophages Infected with Yersinia spp. Methods in Molecular Biology (Clifton, N.J.). 2010: 241-255. PMID 31177443 DOI: 10.1007/978-1-4939-9541-7_17 |
0.485 |
|
| 2019 |
Medici NP, Rashid M, Bliska JB. Characterization of pyrin dephosphorylation and inflammasome activation in macrophages as triggered by the effectors YopE and YopT. Infection and Immunity. PMID 30602502 DOI: 10.1128/Iai.00822-18 |
0.54 |
|
| 2018 |
Fukuto HS, Vadyvaloo V, McPhee JB, Poinar HN, Holmes EC, Bliska JB. A single amino acid change in the response regulator PhoP acquired duringevolution affects PhoP target gene transcription and polymyxin B susceptibility. Journal of Bacteriology. PMID 29440252 DOI: 10.1128/Jb.00050-18 |
0.385 |
|
| 2017 |
Zhang Y, Khairallah C, Sheridan BS, van der Velden AWM, Bliska JB. CCR2+ inflammatory monocytes are recruited to Yersinia pyogranulomas and dictate adaptive responses at the expense of innate immunity during oral infection. Infection and Immunity. PMID 29263104 DOI: 10.1128/Iai.00782-17 |
0.385 |
|
| 2017 |
Kim J, Fukuto HS, Brown DA, Bliska JB, London E. Effects of host cell sterol composition upon internalization of Yersinia pseudotuberculosis and clustered beta-1 integrin. The Journal of Biological Chemistry. PMID 29197826 DOI: 10.1074/Jbc.M117.811224 |
0.442 |
|
| 2017 |
Zwack EE, Feeley E, Burton AR, Hu B, Yamamoto M, Kanneganti TD, Bliska JB, Coers J, Brodsky IE. Guanylate Binding Proteins regulate inflammasome activation in response to hyper-injected Yersinia translocon components. Infection and Immunity. PMID 28784930 DOI: 10.1128/Iai.00778-16 |
0.449 |
|
| 2017 |
Kim J, Fukuto HS, Bliska JB, London E. Effects of Sterol Substitution in Plasma Membrane of Host Cell upon Internalization of Yersinia Pseudotuberculosis Biophysical Journal. 112: 92a. DOI: 10.1016/J.Bpj.2016.11.539 |
0.386 |
|
| 2016 |
Chung LK, Park YH, Zheng Y, Brodsky IE, Hearing P, Kastner DL, Chae JJ, Bliska JB. The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome. Cell Host & Microbe. PMID 27569559 DOI: 10.1016/J.Chom.2016.07.018 |
0.507 |
|
| 2016 |
Schoberle TJ, Chung LK, McPhee JB, Bogin B, Bliska JB. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence. Infection and Immunity. PMID 26810037 DOI: 10.1128/Iai.00843-15 |
0.496 |
|
| 2015 |
Chung LK, Bliska JB. Yersinia versus host immunity: how a pathogen evades or triggers a protective response. Current Opinion in Microbiology. 29: 56-62. PMID 26638030 DOI: 10.1016/J.Mib.2015.11.001 |
0.405 |
|
| 2015 |
Zhang Y, Tam JW, Mena P, van der Velden AW, Bliska JB. CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection. Plos Pathogens. 11: e1005167. PMID 26468944 DOI: 10.1371/Journal.Ppat.1005167 |
0.358 |
|
| 2015 |
Solomon R, Zhang W, McCrann G, Bliska JB, Viboud GI. Random mutagenesis identifies a C-terminal region of YopD important for Yersinia type III secretion function. Plos One. 10: e0120471. PMID 25807250 DOI: 10.1371/Journal.Pone.0120471 |
0.469 |
|
| 2015 |
Zwack EE, Snyder AG, Wynosky-Dolfi MA, Ruthel G, Philip NH, Marketon MM, Francis MS, Bliska JB, Brodsky IE. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD. Mbio. 6: e02095-14. PMID 25691590 DOI: 10.1128/Mbio.02095-14 |
0.418 |
|
| 2014 |
Wang X, Parashar K, Sitaram A, Bliska JB. The GAP activity of type III effector YopE triggers killing of Yersinia in macrophages. Plos Pathogens. 10: e1004346. PMID 25165815 DOI: 10.1371/journal.ppat.1004346 |
0.444 |
|
| 2014 |
Chung LK, Philip NH, Schmidt VA, Koller A, Strowig T, Flavell RA, Brodsky IE, Bliska JB. IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM. Mbio. 5: e01402-14. PMID 24987096 DOI: 10.1128/Mbio.01402-14 |
0.398 |
|
| 2014 |
Bublitz DC, Wright PC, Bodager JR, Rasambainarivo FT, Bliska JB, Gillespie TR. Epidemiology of pathogenic enterobacteria in humans, livestock, and peridomestic rodents in rural Madagascar. Plos One. 9: e101456. PMID 24983990 DOI: 10.1371/Journal.Pone.0101456 |
0.347 |
|
| 2014 |
Szaba FM, Kummer LW, Duso DK, Koroleva EP, Tumanov AV, Cooper AM, Bliska JB, Smiley ST, Lin JS. TNFα and IFNγ but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection. Plos Pathogens. 10: e1004142. PMID 24854422 DOI: 10.1371/Journal.Ppat.1004142 |
0.341 |
|
| 2014 |
Rüter C, Silva MR, Grabowski B, Lubos ML, Scharnert J, Poceva M, von Tils D, Flieger A, Heesemann J, Bliska JB, Schmidt MA. Rabbit monoclonal antibodies directed at the T3SS effector protein YopM identify human pathogenic Yersinia isolates. International Journal of Medical Microbiology : Ijmm. 304: 444-51. PMID 24636859 DOI: 10.1016/J.Ijmm.2014.02.003 |
0.408 |
|
| 2014 |
Ivanov MI, Hill J, Bliska JB. Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV. Clinical and Vaccine Immunology : Cvi. 21: 667-73. PMID 24599533 DOI: 10.1128/CVI.00013-14 |
0.329 |
|
| 2013 |
Bliska JB, Wang X, Viboud GI, Brodsky IE. Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors. Cellular Microbiology. 15: 1622-31. PMID 23834311 DOI: 10.1111/Cmi.12164 |
0.421 |
|
| 2012 |
Bliska JB, van der Velden AW. Salmonella "sops" up a preferred electron receptor in the inflamed intestine. Mbio. 3: e00226-12. PMID 22893385 DOI: 10.1128/Mbio.00226-12 |
0.388 |
|
| 2012 |
Hatkoff M, Runco LM, Pujol C, Jayatilaka I, Furie MB, Bliska JB, Thanassi DG. Roles of chaperone/usher pathways of Yersinia pestis in a murine model of plague and adhesion to host cells. Infection and Immunity. 80: 3490-500. PMID 22851745 DOI: 10.1128/Iai.00434-12 |
0.429 |
|
| 2012 |
Zheng Y, Lilo S, Mena P, Bliska JB. YopJ-induced caspase-1 activation in Yersinia-infected macrophages: independent of apoptosis, linked to necrosis, dispensable for innate host defense. Plos One. 7: e36019. PMID 22563435 DOI: 10.1371/Journal.Pone.0036019 |
0.81 |
|
| 2012 |
McPhee JB, Mena P, Zhang Y, Bliska JB. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM. Infection and Immunity. 80: 2519-27. PMID 22547545 DOI: 10.1128/Iai.06364-11 |
0.405 |
|
| 2012 |
Thanassi DG, Bliska JB, Christie PJ. Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function. Fems Microbiology Reviews. 36: 1046-82. PMID 22545799 DOI: 10.1111/J.1574-6976.2012.00342.X |
0.358 |
|
| 2012 |
Torres R, Chim N, Sankaran B, Pujol C, Bliska JB, Goulding CW. Structural insights into RipC, a putative citrate lyase β subunit from a Yersinia pestis virulence operon. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 68: 2-7. PMID 22232161 DOI: 10.1107/S1744309111048056 |
0.318 |
|
| 2012 |
Klein KA, Fukuto HS, Pelletier M, Romanov G, Grabenstein JP, Palmer LE, Ernst R, Bliska JB. A transposon site hybridization screen identifies galU and wecBC as important for survival of Yersinia pestis in murine macrophages. Journal of Bacteriology. 194: 653-62. PMID 22139502 DOI: 10.1128/Jb.06237-11 |
0.77 |
|
| 2012 |
Zhang Y, Mena P, Romanov G, Lin JS, Smiley ST, Bliska JB. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis. Infection and Immunity. 80: 206-14. PMID 22064714 DOI: 10.1128/Iai.05971-11 |
0.374 |
|
| 2011 |
Torres R, Swift RV, Chim N, Wheatley N, Lan B, Atwood BR, Pujol C, Sankaran B, Bliska JB, Amaro RE, Goulding CW. Biochemical, structural and molecular dynamics analyses of the potential virulence factor RipA from Yersinia pestis. Plos One. 6: e25084. PMID 21966419 DOI: 10.1371/Journal.Pone.0025084 |
0.355 |
|
| 2011 |
Zhang Y, Romanov G, Bliska JB. Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis. Infection and Immunity. 79: 4322-31. PMID 21844228 DOI: 10.1128/Iai.05396-11 |
0.541 |
|
| 2011 |
Zheng Y, Lilo S, Brodsky IE, Zhang Y, Medzhitov R, Marcu KB, Bliska JB. A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages. Plos Pathogens. 7: e1002026. PMID 21533069 DOI: 10.1371/Journal.Ppat.1002026 |
0.813 |
|
| 2011 |
Zhang Y, Bliska JB. Mathematical relationship between cytokine concentrations and pathogen levels during infection. Cytokine. 53: 158-62. PMID 21093285 DOI: 10.1016/J.Cyto.2010.09.008 |
0.403 |
|
| 2010 |
Lin JS, Park S, Adamovicz JJ, Hill J, Bliska JB, Cote CK, Perlin DS, Amemiya K, Smiley ST. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Vaccine. 29: 357-62. PMID 20840834 DOI: 10.1016/J.Vaccine.2010.08.099 |
0.367 |
|
| 2010 |
Fukuto HS, Svetlanov A, Palmer LE, Karzai AW, Bliska JB. Global gene expression profiling of Yersinia pestis replicating inside macrophages reveals the roles of a putative stress-induced operon in regulating type III secretion and intracellular cell division. Infection and Immunity. 78: 3700-15. PMID 20566693 DOI: 10.1128/Iai.00062-10 |
0.454 |
|
| 2010 |
McPhee JB, Mena P, Bliska JB. Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence. Infection and Immunity. 78: 3529-39. PMID 20515922 DOI: 10.1128/Iai.00269-10 |
0.449 |
|
| 2010 |
Brodsky IE, Palm NW, Sadanand S, Ryndak MB, Sutterwala FS, Flavell RA, Bliska JB, Medzhitov R. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host & Microbe. 7: 376-87. PMID 20478539 DOI: 10.1016/J.Chom.2010.04.009 |
0.799 |
|
| 2010 |
Zhang Y, Bliska JB. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection. Infection and Immunity. 78: 2329-41. PMID 20231414 DOI: 10.1128/Iai.00094-10 |
0.396 |
|
| 2010 |
Okan NA, Mena P, Benach JL, Bliska JB, Karzai AW. The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection. Infection and Immunity. 78: 1284-93. PMID 20065026 DOI: 10.1128/Iai.00976-09 |
0.38 |
|
| 2009 |
Noel BL, Lilo S, Capurso D, Hill J, Bliska JB. Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages. Clinical and Vaccine Immunology : Cvi. 16: 1457-66. PMID 19710295 DOI: 10.1128/Cvi.00172-09 |
0.772 |
|
| 2009 |
Klein KA, Bliska JB. How Yersinia pestis becomes a foreign obstruction in the digestive system of the macrophage. Autophagy. 5: 882-3. PMID 19550144 DOI: 10.4161/Auto.9095 |
0.721 |
|
| 2009 |
Pujol C, Klein KA, Romanov GA, Palmer LE, Cirota C, Zhao Z, Bliska JB. Yersinia pestis can reside in autophagosomes and avoid xenophagy in murine macrophages by preventing vacuole acidification. Infection and Immunity. 77: 2251-61. PMID 19289509 DOI: 10.1128/Iai.00068-09 |
0.725 |
|
| 2009 |
Bliska JB, Casadevall A. Intracellular pathogenic bacteria and fungi--a case of convergent evolution? Nature Reviews. Microbiology. 7: 165-71. PMID 19098923 DOI: 10.1038/Nrmicro2049 |
0.375 |
|
| 2008 |
Ivanov MI, Noel BL, Rampersaud R, Mena P, Benach JL, Bliska JB. Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis. Infection and Immunity. 76: 5181-90. PMID 18765742 DOI: 10.1128/Iai.00189-08 |
0.762 |
|
| 2008 |
Zhang Y, Murtha J, Roberts MA, Siegel RM, Bliska JB. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages. Infection and Immunity. 76: 4299-310. PMID 18591234 DOI: 10.1128/Iai.00183-08 |
0.562 |
|
| 2008 |
Lilo S, Zheng Y, Bliska JB. Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ. Infection and Immunity. 76: 3911-23. PMID 18559430 DOI: 10.1128/Iai.01695-07 |
0.808 |
|
| 2008 |
Mejía E, Bliska JB, Viboud GI. Yersinia controls type III effector delivery into host cells by modulating Rho activity. Plos Pathogens. 4: e3. PMID 18193942 DOI: 10.1371/Journal.Ppat.0040003 |
0.434 |
|
| 2006 |
Bliska JB. Yersinia inhibits host signaling by acetylating MAPK kinases. Acs Chemical Biology. 1: 349-51. PMID 17163770 DOI: 10.1021/Cb600261K |
0.42 |
|
| 2006 |
Prehna G, Ivanov MI, Bliska JB, Stebbins CE. Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors. Cell. 126: 869-80. PMID 16959567 DOI: 10.1016/J.Cell.2006.06.056 |
0.474 |
|
| 2006 |
Viboud GI, Mejía E, Bliska JB. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection. Cellular Microbiology. 8: 1504-15. PMID 16922868 DOI: 10.1111/J.1462-5822.2006.00729.X |
0.398 |
|
| 2006 |
Grabenstein JP, Fukuto HS, Palmer LE, Bliska JB. Characterization of phagosome trafficking and identification of PhoP-regulated genes important for survival of Yersinia pestis in macrophages. Infection and Immunity. 74: 3727-41. PMID 16790745 DOI: 10.1128/Iai.00255-06 |
0.799 |
|
| 2006 |
Okan NA, Bliska JB, Karzai AW. A Role for the SmpB-SsrA system in Yersinia pseudotuberculosis pathogenesis. Plos Pathogens. 2: e6. PMID 16450010 DOI: 10.1371/Journal.Ppat.0020006 |
0.466 |
|
| 2006 |
Bliska JB, Ryndak MB, Grabenstein JP. Type III secretion systems in yersinia pestis and yersinia pseudotuberculosis Bacterial Genomes and Infectious Diseases. 213-226. DOI: 10.1007/978-1-59745-152-9_12 |
0.735 |
|
| 2005 |
Hudson KJ, Bliska JB, Bouton AH. Distinct mechanisms of integrin binding by Yersinia pseudotuberculosis adhesins determine the phagocytic response of host macrophages. Cellular Microbiology. 7: 1474-89. PMID 16153246 DOI: 10.1111/J.1462-5822.2005.00571.X |
0.402 |
|
| 2005 |
Pujol C, Grabenstein JP, Perry RD, Bliska JB. Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus. Proceedings of the National Academy of Sciences of the United States of America. 102: 12909-14. PMID 16120681 DOI: 10.1073/Pnas.0502849102 |
0.793 |
|
| 2005 |
Zhang Y, Ting AT, Marcu KB, Bliska JB. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. Journal of Immunology (Baltimore, Md. : 1950). 174: 7939-49. PMID 15944300 DOI: 10.4049/Jimmunol.174.12.7939 |
0.426 |
|
| 2005 |
Viboud GI, Bliska JB. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annual Review of Microbiology. 59: 69-89. PMID 15847602 DOI: 10.1146/Annurev.Micro.59.030804.121320 |
0.466 |
|
| 2005 |
Zhang Y, Bliska JB. Role of macrophage apoptosis in the pathogenesis of Yersinia Current Topics in Microbiology and Immunology. 289: 151-173. PMID 15791955 DOI: 10.1007/3-540-27320-4_7 |
0.472 |
|
| 2005 |
Ryndak MB, Chung H, London E, Bliska JB. Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein. Infection and Immunity. 73: 2433-43. PMID 15784589 DOI: 10.1128/Iai.73.4.2433-2443.2005 |
0.785 |
|
| 2005 |
Pujol C, Bliska JB. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clinical Immunology (Orlando, Fla.). 114: 216-26. PMID 15721832 DOI: 10.1016/J.Clim.2004.07.013 |
0.504 |
|
| 2005 |
Ivanov MI, Stuckey JA, Schubert HL, Saper MA, Bliska JB. Two substrate-targeting sites in the Yersinia protein tyrosine phosphatase co-operate to promote bacterial virulence. Molecular Microbiology. 55: 1346-56. PMID 15720545 DOI: 10.1111/J.1365-2958.2005.04477.X |
0.416 |
|
| 2004 |
Grabenstein JP, Marceau M, Pujol C, Simonet M, Bliska JB. The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence. Infection and Immunity. 72: 4973-84. PMID 15321989 DOI: 10.1128/Iai.72.9.4973-4984.2004 |
0.797 |
|
| 2004 |
Roy D, Liston DR, Idone VJ, Di A, Nelson DJ, Pujol C, Bliska JB, Chakrabarti S, Andrews NW. A process for controlling intracellular bacterial infections induced by membrane injury. Science (New York, N.Y.). 304: 1515-8. PMID 15178804 DOI: 10.1126/Science.1098371 |
0.371 |
|
| 2003 |
Pujol C, Bliska JB. The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infection and Immunity. 71: 5892-9. PMID 14500510 DOI: 10.1128/Iai.71.10.5892-5899.2003 |
0.435 |
|
| 2003 |
Liang F, Huang Z, Lee SY, Liang J, Ivanov MI, Alonso A, Bliska JB, Lawrence DS, Mustelin T, Zhang ZY. Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague. The Journal of Biological Chemistry. 278: 41734-41. PMID 12888560 DOI: 10.1074/Jbc.M307152200 |
0.359 |
|
| 2003 |
McDonald C, Vacratsis PO, Bliska JB, Dixon JE. The yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. The Journal of Biological Chemistry. 278: 18514-23. PMID 12626518 DOI: 10.1074/Jbc.M301226200 |
0.314 |
|
| 2003 |
Viboud GI, So SS, Ryndak MB, Bliska JB. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis. Molecular Microbiology. 47: 1305-15. PMID 12603736 DOI: 10.1046/J.1365-2958.2003.03350.X |
0.79 |
|
| 2003 |
Zhang Y, Bliska JB. Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infection and Immunity. 71: 1513-9. PMID 12595470 DOI: 10.1128/Iai.71.3.1513-1519.2003 |
0.441 |
|
| 2002 |
Viboud GI, Bliska JB. Measurement of pore formation by contact-dependent type III protein secretion systems. Methods in Enzymology. 358: 345-50. PMID 12474398 DOI: 10.1016/S0076-6879(02)58100-3 |
0.358 |
|
| 2002 |
Orth K, Dixon JE, Bliska JB. 20 Effector proteins of bacterial type III protein secretion systems: Elucidating their biochemical effects on eukaryotic signaling cascades Methods in Microbiology. 31: 361-376. DOI: 10.1016/S0580-9517(02)31021-3 |
0.414 |
|
| 2001 |
Viboud GI, Bliska JB. A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes Embo Journal. 20: 5373-5382. PMID 11574469 DOI: 10.1093/Emboj/20.19.5373 |
0.432 |
|
| 2001 |
Montagna LG, Ivanov MI, Bliska JB. Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition. The Journal of Biological Chemistry. 276: 5005-11. PMID 11069923 DOI: 10.1074/Jbc.M009045200 |
0.762 |
|
| 2000 |
Weidow CL, Black DS, Bliska JB, Bouton AH. CAS/Crk signalling mediates uptake of Yersinia into human epithelial cells. Cellular Microbiology. 2: 549-60. PMID 11207607 DOI: 10.1046/J.1462-5822.2000.00079.X |
0.375 |
|
| 2000 |
Black DS, Marie-Cardine A, Schraven B, Bliska JB. The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages. Cellular Microbiology. 2: 401-14. PMID 11207596 DOI: 10.1046/J.1462-5822.2000.00061.X |
0.447 |
|
| 2000 |
Black DS, Bliska JB. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Molecular Microbiology. 37: 515-27. PMID 10931345 DOI: 10.1046/J.1365-2958.2000.02021.X |
0.459 |
|
| 1999 |
Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector Science. 285: 1920-1923. PMID 10489373 DOI: 10.1126/Science.285.5435.1920 |
0.414 |
|
| 1999 |
Palmer LE, Pancetti AR, Greenberg S, Bliska JB. YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells Infection and Immunity. 67: 708-716. PMID 9916081 DOI: 10.1128/Iai.67.2.708-716.1999 |
0.423 |
|
| 1998 |
Black DS, Montagna LG, Zitsmann S, Bliska JB. Identification of an amino-terminal substrate-binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets. Molecular Microbiology. 29: 1263-74. PMID 9767593 DOI: 10.1046/J.1365-2958.1998.01014.X |
0.753 |
|
| 1998 |
Palmer LE, Hobble S, Galán JE, Bliska JB. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-α production and downregulation of the MAP kinases p38 and JNK Molecular Microbiology. 27: 953-965. PMID 9535085 DOI: 10.1046/J.1365-2958.1998.00740.X |
0.398 |
|
| 1997 |
Black DS, Bliska JB. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. The Embo Journal. 16: 2730-44. PMID 9184219 DOI: 10.1093/Emboj/16.10.2730 |
0.436 |
|
| 1996 |
Galán JE, Bliska JB. Cross-talk between bacterial pathogens and their host cells Annual Review of Cell and Developmental Biology. 12: 221-255. PMID 8970727 DOI: 10.1146/Annurev.Cellbio.12.1.221 |
0.416 |
|
| 1996 |
Kaniga K, Uralil J, Bliska JB, Galán JE. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium Molecular Microbiology. 21: 633-641. PMID 8866485 DOI: 10.1111/J.1365-2958.1996.Tb02571.X |
0.462 |
|
| 1996 |
Bliska J. How pathogens exploit interactions mediated by SH3 domains Chemistry and Biology. 3: 7-11. PMID 8807821 DOI: 10.1016/S1074-5521(96)90076-9 |
0.408 |
|
| 1995 |
Bliska JB, Black DS. Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase. Infection and Immunity. 63: 681-5. PMID 7822039 DOI: 10.1128/Iai.63.2.681-685.1995 |
0.471 |
|
| 1993 |
Bliska JB, Galán JE, Falkow S. Signal transduction in the mammalian cell during bacterial attachment and entry. Cell. 73: 903-20. PMID 8500180 DOI: 10.1016/0092-8674(93)90270-Z |
0.313 |
|
| 1993 |
Bliska JB, Falkow S. The role of host tyrosine phosphorylation in bacterial pathogenesis. Trends in Genetics : Tig. 9: 85-9. PMID 8488567 DOI: 10.1016/0168-9525(93)90229-B |
0.419 |
|
| 1993 |
Bliska JB, Copass MC, Falkow S. The Yersinia pseudotuberculosis adhesin YadA mediates intimate bacterial attachment to and entry into HEp-2 cells. Infection and Immunity. 61: 3914-21. PMID 7689542 |
0.338 |
|
| 1992 |
Bliska JB, Falkow S. Bacterial resistance to complement killing mediated by the Ail protein of Yersinia enterocolitica. Proceedings of the National Academy of Sciences of the United States of America. 89: 3561-5. PMID 1565652 DOI: 10.1073/Pnas.89.8.3561 |
0.394 |
|
| 1992 |
Bliska JB, Clemens JC, Dixon JE, Falkow S. The Yersinia tyrosine phosphatase: specificity of a bacterial virulence determinant for phosphoproteins in the J774A.1 macrophage. The Journal of Experimental Medicine. 176: 1625-30. PMID 1281213 DOI: 10.1084/Jem.176.6.1625 |
0.462 |
|
| 1991 |
Clemens JC, Guan K, Bliska JB, Falkow S, Dixon JE. Microbial pathogenesis and tyrosine dephosphorylation: surprising 'bedfellows'. Molecular Microbiology. 5: 2617-20. PMID 1723471 DOI: 10.1111/J.1365-2958.1991.Tb01970.X |
0.326 |
|
| 1991 |
Bliska JB, Guan KL, Dixon JE, Falkow S. Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proceedings of the National Academy of Sciences of the United States of America. 88: 1187-91. PMID 1705028 DOI: 10.1073/Pnas.88.4.1187 |
0.468 |
|
| 1990 |
Miller VL, Bliska JB, Falkow S. Nucleotide sequence of the Yersinia enterocolitica ail gene and characterization of the Ail protein product. Journal of Bacteriology. 172: 1062-9. PMID 1688838 DOI: 10.1128/Jb.172.2.1062-1069.1990 |
0.362 |
|
| Show low-probability matches. |